It has been reported that some enzymes have the ability to either activate or inactivate complement activity (3, 8) . At least for two of these, streptokinase and L-asparaginase, anti-or procomplementary effects were shown to be due to bacterial contaminants in the enzyme preparation (5, 6) and not to the enzymes themselves. We now present evidence that a phospholipase C preparation derived from Clostridium welchii was capable of interacting with Cl in serum and that this interaction was due to substances that are separable from enzyme activity. The interaction of the phospholipase C preparation with Cl in serum may result in activation or inactivation of Cl activity.
Reagents and buffers used in the following experiments were described by Rapp and Borsos (9) . Cl and C1 activity in whole serum was determined by measuing the the generation of EAC14 at the end of 10 min of incubation at 30 C of EAC4 with dilutions of whole serum. The doseresponse curve of C1 under these conditions is linear (1) , and a longer time of incubation at 30 C has no effect on the extent of lysis as a function of C1 concentration. On the other hand, the dose-response curve of precursor Cl is not linear (11) , and further incubation leads to increased lysis for a given concentration of Cl without resulting in a linear dose-response curve (Fig. 1) . Based on these observations, activated and nonactivated Cl can be distinguished by comparing the shapes of their dose-response curves; furthermore, a shift in the angles of the dose-response curves sheep erythrocytes as described in (10) . Sephadex chromatography was performed as described (2) . To determine whether phospholipase C has an effect on Cl in guinea pig and human sera, equal volumes of undiluted guinea pig or un-VOL. 6, 1972 NOTES diluted human serum and dilutions of phospholipase C (diluted in Veronal-buffered saline, VBS, ,u = 0.065, pH 7.3) were mixed together and incubated for 30 min at 37 C. At this time, the mixtures were diluted in VBS, (IA = 0.065), and the amount and nature of Cl were determined. The results in Fig. 2 show that the phospholipase C preparation inactivated Cl in guinea pig serum and human serum MS, and that phospholipase C did not convert Cl to C1. In contrast, phospholipase C was capable of activating Cl to C1 in human serum FS (Fig. 3) ; however, inactivation of Cl and C1 occurred when phospholipase C was incubated with human serum FS at 0 C (Fig. 3) . Since phospholipase C was derived from bacteria, we considered the possibility that the effect of phospholipase C preparations on C1 may be due to a contaminant and not to the enzyme phospholipase C. To test this hypothesis, we subjected the phospholipase C preparation to molecular sieve chromatography on Sephadex G-200. The effluent was tested for phospholipase C activity and for interaction with serum C1. The interaction with serum Cl was tested by incubating equal volumes (0.1 ml) of undiluted serum and undiluted effluent for 30 min at 37 C. At this time, the mixtures were diluted (final serum dilution 1:100,000 in VBS, ,u = 0.065, pH 7.3), and the amount of Cl was determined as described above. The results of this experiment are shown in Fig. 4 . We found two activities which inhibited serum Cl; one appeared in the void volume and the other was retarded by the beads and its position with respect to serum proteins was between the 7S and albumin peaks. The phospholipase C activity was eluted after the second peak of anti-Cl activity. These results showed that the enzyme phospholipase C has no effect on Cl in human or in guinea pig serum. The inhibitory effect of the contaminant(s) on Cl of human as well as guinea pig serum may be due to proteinase(s) since it is known from work by Goldlust et al. that proteinases derived from Clostridium sp. inactivate whole serum complement activity (4, 7). The proteinase isolated by Goldlust inactivated C2 but not Cl (4); our experiments also showed that Clostridium preparations also contain an inactivator of Cl. The activation of Cl noted in one of the sera tested after incubation with the phospholipase C preparation is explainable as a result of antibody-anti- 
